HTEC Holdings — ROBO Global(R) Healthcare Technology and Innovation ETF
All 61 reported holdings of ROBO Global(R) Healthcare Technology and Innovation ETF (HTEC) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| AxoGen, Inc. | 3.16% | $1.68M |
| Arrowhead Pharmaceuticals, Inc. | 2.56% | $1.37M |
| Twist Bioscience Corp | 2.34% | $1.25M |
| Glaukos Corporation | 2.22% | $1.19M |
| Natera, Inc. | 2.17% | $1.16M |
| Tempus Ai, Inc. | 2.13% | $1.13M |
| Novocure Limited | 2.04% | $1.09M |
| Alnylam Pharmaceuticals, Inc. | 2.01% | $1.07M |
| Guardant Health, Inc. | 1.99% | $1.06M |
| Thermo Fisher Scientific Incorporated | 1.99% | $1.06M |
| Vertex Pharmaceuticals Incorporated | 1.95% | $1.04M |
| Illumina, Inc. | 1.95% | $1.04M |
| Intuitive Surgical, Inc. | 1.95% | $1.04M |
| Grail Inc | 1.90% | $1.01M |
| Globus Medical, Inc. | 1.86% | $990.09K |
| Penumbra, Inc. | 1.85% | $986.30K |
| Livanova PLC | 1.84% | $984.02K |
| Edwards Lifesciences Corporation | 1.84% | $983.96K |
| Caredx, Inc. | 1.84% | $983.23K |
| Stryker Corporation | 1.80% | $960.52K |
| Lonza Group AG | 1.80% | $957.73K |
| United Therapeutics Corporation | 1.79% | $956.44K |
| Siemens Healthineers AG | 1.79% | $953.18K |
| Regeneron Pharmaceuticals, Inc. | 1.78% | $951.70K |
| Incyte Corporation | 1.78% | $949.56K |
| Irhythm Holdings, Inc. | 1.78% | $947.00K |
| Artivion, Inc. | 1.77% | $946.66K |
| Adaptive Biotechnologies Corp | 1.74% | $928.70K |
| Iqvia Holdings, Inc. | 1.73% | $923.61K |
| Medpace Holdings, Inc. | 1.72% | $919.80K |
| Koninklijke Philips N.V. | 1.72% | $916.92K |
| Boston Scientific Corporation | 1.68% | $897.91K |
| Danaher Corporation | 1.68% | $895.82K |
| Novanta Inc. | 1.67% | $889.22K |
| Bio-Rad Laboratories, Inc. | 1.64% | $876.50K |
| Veracyte Inc | 1.64% | $876.03K |
| Eurofins Scientific SE | 1.64% | $875.18K |
| JD Health International Inc | 1.63% | $867.97K |
| Agilent Technologies, Inc. | 1.62% | $865.59K |
| Bristol-Myers Squibb Company | 1.54% | $821.36K |
| Tecan Group AG | 1.51% | $806.39K |
| Roche Holding AG | 1.49% | $795.95K |
| Charles River Laboratories International, Inc. | 1.49% | $792.94K |
| Abbott Laboratories | 1.49% | $792.51K |
| Integra Lifesciences Holdings Corporation | 1.43% | $765.06K |
| Becton, Dickinson And Company | 1.38% | $733.43K |
| Ge Healthcare Technologies Inc. | 1.35% | $722.05K |
| Align Technology, Inc. | 1.35% | $719.35K |
| Moderna, Inc. | 1.30% | $695.49K |
| Conmed Corporation | 1.28% | $684.55K |
| Biomarin Pharmaceutical Inc. | 1.27% | $676.84K |
| Qiagen N.V. | 1.26% | $673.34K |
| Diasorin S.p.a. | 1.24% | $663.52K |
| Omnicell, Inc. | 1.24% | $661.48K |
| Smith & Nephew PLC | 1.12% | $595.78K |
| Revvity, Inc. | 1.09% | $579.92K |
| PeptiDream Inc. | 0.97% | $519.29K |
| Veeva Systems Inc. | 0.96% | $510.18K |
| Alibaba Health Information Technology Limited | 0.96% | $509.87K |
| Bank Of New York (the) | 0.00% | $-12 |
| Bank Of New York (the) | 0.00% | $-7 |
HTEC overview: performance, fees, allocation and SEC filings